Ati cautat: monitorizare riscuri
Protocol terapeutic: L01XX27 – DCI ARSENICUM TRIOXIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE21 – DCI REGORAFENIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC32 – DCI ATEZOLIZUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: J05AP56 – DCI SOFOSBUVIRUM+VELPATASVIRUM+VOXILAPREVIRUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB17 – DCI CERLIPONASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX50 – DCI IXAZOMIB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC31 – DCI AVELUMABUM (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: L01XC02 – DCI RITUXIMABUM (ORIGINAL ȘI BIOSIMILAR) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: C07FX05 – DCI COMBINAŢII (METOPROLOLUM + IVABRADINUM) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AX14 – DCI MIGALASTATUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
